False positives more likely in heart disorder genetic testing for black patients

According to a new study, genetic testing is more likely to turn up false positives for black people than white people when looking for mutations related to hypertrophic cardiomyopathy.

According to the New York Times, the discrepancy comes from a lack of diversity in early trials surrounding the testing. There weren’t enough people included belonging to racial and ethnic minority groups, so researchers couldn’t get a full picture of what the mutations might look like in people who weren’t white.

And the cases of mistaken genetic testing could extend beyond this one condition.

The false positives in testing could cause problems for the patients mistakenly believing they have a rare heart disorder, such as emotional trauma and undergoing unnecessary procedures.

Check out the New York Times to see how the mistake could be affecting testing for other disorders and diseases. 

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup